Phenomenex Announces Swiss Service Changes
Phenomenex Inc. has announced that it will begin to directly serve customers in Switzerland following the mutually agreed upon end of its 26-year-old partnership with local distributor Brechbühler AG.
Phenomenex Inc. has announced that it will begin to directly serve customers in Switzerland following the mutually agreed upon end of its 26-year-old partnership with local distributor Brechbühler AG.
Phenomenex customers in Switzerland will now have access to a variety of services such as comprehensive technical training and support services, live technical chat, online ordering, increased product availability, and rapid shipping times.
Shane Lyons, President of Phenomenex commented: “We will always be indebted to Brechbühler AG for such a successful partnership. Going forward, we are excited for the opportunity to directly serve our Swiss customers with our world-class technical support and customer intimate service model. We are thrilled to be expanding our global operations to better serve our customers.”
Distribution changes came into effect on 1st September 2017.
For more information on Phenomenex, please visit www.phenomenex.com
GC–TOF-MS Finds 250 Volatile Compounds in E-Cigarette Liquids
November 1st 2024A study has used gas chromatography coupled to a time-of-flight mass spectrometer to build an electron ionization mass spectra database of more than 250 chemicals classified as either volatile or semi-volatile compounds. An additional, confirmatory layer of liquid chromatography–mass spectrometry analysis was subsequently performed.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Multivariate Design of Experiments for Gas Chromatographic Analysis
November 1st 2024Recent advances in green chemistry have made multivariate experimental design popular in sample preparation development. This approach helps reduce the number of measurements and data for evaluation and can be useful for method development in gas chromatography.
